Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases
Antioxidants · 25.09.2024 · 13 (10) · 1163
DOI: 10.3390/antiox13101163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 25.09.2024. Verfasst von Cristina Manuela Drăgoi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 020956 Bucharest, Romania. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy Carol Davila.
Abstract (Originalsprache)
Precision medicine is envisioned as the future of cardiovascular healthcare, offering a more tailored and effective method for managing cardiovascular diseases compared to the traditional one-size-fits-all approaches. The complex role of oxidative stress in chronic diseases within the framework of precision medicine was carefully explored, delving into the cellular redox status and its critical involvement in the pathophysiological complexity of cardiovascular diseases (CVDs). The review outlines the mechanisms of reactive oxygen species generation and the function of antioxidants in maintaining redox balance. It emphasizes the elevated reactive oxygen species concentrations observed in heart failure and their detrimental impact on cardiovascular health. Various sources of ROS within the cardiovascular system are examined, including mitochondrial dysfunction, which contributes to oxidative stress and mitochondrial DNA degradation. The article also addresses oxidative stress’s role in myocardial remodeling, a process pivotal to the progression of heart diseases. By integrating these aspects, the review underscores the importance of redox homeostasis and identifies molecular biomarkers that can enhance precision therapy for CVDs. The insights provided aim to pave the way for targeted therapeutic strategies that mitigate oxidative stress, thereby improving patient outcomes in cardiovascular medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 020956 Bucharest, Romania.
- Faculty of Medicine, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.
- Department of Internal Medicine, Clinical Emergency Hospital of Bucharest, 105402 Bucharest, Romania.
ORCID-Profile: Cristina Manuela Drăgoi, Camelia Cristina Diaconu, Alina Crenguța Nicolae, Ion-Bogdan Dumitrescu
Förderung
- University of Medicine and Pharmacy Carol Davila
Zitieren
APA
Drăgoi, C. M., Diaconu, C. C., Nicolae, A. C., & Dumitrescu, I. B. (2024). Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases. Antioxidants, 13(10), 1163. https://doi.org/10.3390/antiox13101163
Vancouver
Drăgoi CM, Diaconu CC, Nicolae AC, Dumitrescu IB. Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases. Antioxidants. 2024;13(10):1163. doi:10.3390/antiox13101163
BibTeX
@article{Drgoi2024,
author = {Drăgoi, Cristina Manuela and Diaconu, Camelia Cristina and Nicolae, Alina Crenguța and Dumitrescu, Ion-Bogdan},
title = {Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {10},
pages = {1163},
doi = {10.3390/antiox13101163}
}
EUVIMED